H. Dalyanoglu, “Conversion of Atrial Fibrillation after Cardiosurgical Procedures by Vernakalant® as an Atrial Repolarization Delaying Agent (ARDA)”, HSF, vol. 21, no. 3, pp. E201-E208, May 2018.